The first evidence of such applications was published in Steidler et al. [75], where engineered secretion of interleukin-10 (IL-10) in L. lactis was used to treat inflammatory bowel disease (IBD) in colitis-induced mice. Here, IL10 is linked to inflammatory bowel disease.